> Back to JHP Titles

Validation of Employer-Focused Actuarial Model for Measuring the Economic Burden of Chronic Obstructive Pulmonary Disease

1. Cooper CB.  The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119:S21-S31.

2. Centers for Disease Control. Facts about chronic obstructive pulmonary disease.  August 2003.

3. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Report, 2006. http://www.goldcopd.com

4. Foster, TS, Miller JD, Marton JP, et al. Assessment of the economic burden of COPD in the US: A review and synthesis of the literature. COPD 2006; 3: 211-18.

5. Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: What is the true burden of disease?  Chest 2003; 123: 1684-92.

6. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends.  Lancet 2007; 370: 765-73.

7. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD).  Lancet 2004; 364: 613-20.

8. Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP.  A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. Journal of Occupational & Environmental Medicine 2007; 49(1): 22-30.

9. Goetzel RZ, Long ST, Ozminkowski RJ, Hawkins K, Wang W, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers.  Journal of Occupational and Environmental Medicine 2004; 46(4): 398-412 .

10. Hnizdo E., Sullivan, PA, Bang KM, G. Wagner.  Association between COPD and employment by industry and occupation in the US population: A study of data from the Third National Health and Nutrition Examination Survey.  American Journal of Epidemiology 2002; 156(8), 738-46.